These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 8112390)
21. Sigma-1 and sigma-2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns. McCann DJ; Weissman AD; Su TP Synapse; 1994 Jul; 17(3):182-9. PubMed ID: 7974201 [TBL] [Abstract][Full Text] [Related]
22. Discrimination of (+)-3-PPP sites from DTG sites by FH-510, a novel potent sigma ligand, in rat brain. Chaki S; Tanaka M; Muramatsu M; Otomo S Eur J Pharmacol; 1993 Nov; 250(1):173-5. PubMed ID: 7907020 [TBL] [Abstract][Full Text] [Related]
23. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes. Nguyen VH; Kassiou M; Johnston GA; Christie MJ Eur J Pharmacol; 1996 Sep; 311(2-3):233-40. PubMed ID: 8891604 [TBL] [Abstract][Full Text] [Related]
24. A sigma-like binding site in rat pheochromocytoma (PC12) cells: decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Hellewell SB; Bowen WD Brain Res; 1990 Sep; 527(2):244-53. PubMed ID: 2174717 [TBL] [Abstract][Full Text] [Related]
25. 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Weber E; Sonders M; Quarum M; McLean S; Pou S; Keana JF Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8784-8. PubMed ID: 2877462 [TBL] [Abstract][Full Text] [Related]
26. Possible involvement of a sigma receptor subtype in the neck dystonia in rats. Nakazawa M; Kobayashi T; Matsuno K; Mita S Pharmacol Biochem Behav; 1999 Jan; 62(1):123-6. PubMed ID: 9972854 [TBL] [Abstract][Full Text] [Related]
27. Labeling by [3H]1,3-di(2-tolyl)guanidine of two high affinity binding sites in guinea pig brain: evidence for allosteric regulation by calcium channel antagonists and pseudoallosteric modulation by sigma ligands. Rothman RB; Reid A; Mahboubi A; Kim CH; De Costa BR; Jacobson AE; Rice KC Mol Pharmacol; 1991 Feb; 39(2):222-32. PubMed ID: 1847495 [TBL] [Abstract][Full Text] [Related]
28. 1,3-Di(2-[5-3H]tolyl)guanidine labels more than one site in rat forebrain. Codd EE; Shank RP Eur J Pharmacol; 1992 Jul; 217(2-3):149-52. PubMed ID: 1425936 [TBL] [Abstract][Full Text] [Related]
29. sigma receptors in rat brain and testes show similar reductions in response to chronic haloperidol. Jansen KL; Elliot M; Leslie RA Eur J Pharmacol; 1992 Apr; 214(2-3):281-3. PubMed ID: 1325359 [TBL] [Abstract][Full Text] [Related]
30. Alterations in N-methyl-D-aspartate receptor binding in dystonic hamster brains. Nobrega JN; Richter A; Jiwa D; Raymond R; Löscher W Brain Res; 1997 Jan; 744(1):161-5. PubMed ID: 9030427 [TBL] [Abstract][Full Text] [Related]
31. Identification of the binding subunit of the sigma-type opiate receptor by photoaffinity labeling with 1-(4-azido-2-methyl[6-3H]phenyl)-3-(2-methyl[4,6-3H]phenyl)guanidine. Kavanaugh MP; Tester BC; Scherz MW; Keana JF; Weber E Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2844-8. PubMed ID: 2833756 [TBL] [Abstract][Full Text] [Related]
32. Differential effects of cytochrome P-450 induction on ligand binding to sigma receptors. Basile AS; Paul IA; de Costa B Eur J Pharmacol; 1992 Sep; 227(1):95-8. PubMed ID: 1426026 [TBL] [Abstract][Full Text] [Related]
33. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations. Dumont M; Lemaire S Eur J Pharmacol; 1991 Dec; 209(3):245-8. PubMed ID: 1665796 [TBL] [Abstract][Full Text] [Related]
34. Receptor binding profiles of KB-5492, a novel anti-ulcer agent, at sigma receptors in guinea-pig brain. Harada Y; Hara H; Sukamoto T Eur J Pharmacol; 1994 May; 256(3):321-8. PubMed ID: 8045277 [TBL] [Abstract][Full Text] [Related]
35. Binding of sigma-ligands to C57BL/6 mouse brain membranes: effects of monoamine oxidase inhibitors and subcellular distribution studies suggest the existence of sigma-receptor subtypes. Itzhak Y; Stein I; Zhang SH; Kassim CO; Cristante D J Pharmacol Exp Ther; 1991 Apr; 257(1):141-8. PubMed ID: 1850463 [TBL] [Abstract][Full Text] [Related]
36. Sigma receptors are highly concentrated in the rat pineal gland. Jansen KL; Dragunow M; Faull RL Brain Res; 1990 Jan; 507(1):158-60. PubMed ID: 2154298 [TBL] [Abstract][Full Text] [Related]
37. Autoradiographic and pharmacological studies on the role of dopamine D3 receptors in genetically dystonic (dt(sz)) hamsters. Sander SE; Raymond R; Nobrega JN; Richter A Pharmacol Biochem Behav; 2010 Aug; 96(2):136-40. PubMed ID: 20451545 [TBL] [Abstract][Full Text] [Related]
38. Haloperidol treatment differentially regulates [3H]DTG and [3H](+)-3-PPP labeled sigma binding sites. Bailey MA; Karbon EW Eur J Pharmacol; 1993 Aug; 240(2-3):243-50. PubMed ID: 7902283 [TBL] [Abstract][Full Text] [Related]
39. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Vilner BJ; John CS; Bowen WD Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973 [TBL] [Abstract][Full Text] [Related]
40. NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain. Chaki S; Tanaka M; Muramatsu M; Otomo S Eur J Pharmacol; 1994 Jan; 251(1):R1-2. PubMed ID: 8137864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]